LifeStance Health Group, Inc. (LFST)

LifeStance Health Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2019
Net Income	-186.26	-215.56	-343.95	-58.9
Depreciation & Amortization	120.42	107.36	54.14	6.1
Share-Based Compensation	99.39	187.43	259.44	0.05
Other Operating Activities	-50.43	-26.44	39.79	5.23
Operating Cash Flow	-16.88	52.79	9.42	17.05
Operating Cash Flow Growth	-	460.39%	-44.74%	-
Capital Expenditures	-40.52	-79.26	-94.49	-14.31
Acquisitions	-19.82	-60.21	-99.58	-59.06
Investing Cash Flow	-60.34	-139.46	-194.08	-73.38
Share Issuance / Repurchase	0	0	549.91	0
Debt Issued / Paid	55.1	60.68	-223.77	53.49
Other Financing Activities	-7.67	-13.42	-12.28	-5.02
Financing Cash Flow	47.43	47.26	313.86	48.46
Net Cash Flow	-29.8	-39.41	129.2	-7.86
Free Cash Flow	-57.4	-26.47	-85.07	2.73
Free Cash Flow Margin	-5.44%	-3.08%	-12.74%	1.29%
Free Cash Flow Per Share	-0.16	-0.07	-0.26	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).